Non-prescription pills draws controversy

Feb 05, 2007

A new plan in Britain that would allow birth control pills to be available for sale without prescription has some area doctors concerned, a report said.

Several British doctors have asked the Medicines and Healthcare Regulatory Authority to consider the new plan carefully because such medication sometimes can have major side effects, the Daily Mail reported.

While the proposal does call for any pharmacist offering birth control pills over the counter to check out a customer's medical history, the doctors remain concerned about the legislation.

They said the medication can especially prove dangerous to women who are already vulnerable to blood clots.

Those doctors will be given a chance to voice their opposition to the proposal at a meeting on Tuesday with drug industry representatives, along with National Health Service and other government officials.

The Daily Mail said similar legislation was previously passed for a migraine medication and cholesterol-lowering statins.

Copyright 2007 by United Press International

Explore further: First clinical trial for new skin wound-healing compound is a success

add to favorites email to friend print save as pdf

Related Stories

Video games target Japan's silver generation

Mar 06, 2014

At a nursing home in suburban Tokyo, 88-year-old Saburo Sakamoto darts his fingers energetically to catch characters that appear on a touch screen in front of him.

Emerging ethical dilemmas in science and technology

Dec 10, 2013

As a new year approaches, the University of Notre Dame's John J. Reilly Center for Science, Technology and Values has released its annual list of emerging ethical dilemmas and policy issues in science and ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

User comments : 0